location: Current position: Home >> Scientific Research >> Paper Publications

Investigation into the mechanism of Eucommia ulmoides Oliv. based on a systems pharmacology approach

Hits:

Indexed by:期刊论文

Date of Publication:2014-01-10

Journal:JOURNAL OF ETHNOPHARMACOLOGY

Included Journals:SCIE、PubMed、Scopus

Volume:151

Issue:1

Page Number:452-460

ISSN No.:0378-8741

Key Words:Traditional Chinese Medicine; Eucommia ulmoides Oliv.; Systems pharmacology; Network analysis

Abstract:Ethnopharmacology relevance: Though Traditional Chinese Medicine (TCM) has long been playing a significant role in the maintenance of health for people in Asia as well as many other places, the mechanism of its action still remains ambiguous for most of the plants used in TCM, such as Eucommia ulmoides Oliv., a kind of herb that is widely used to help regulate hypertension and the immune system nowadays. However, its functioning mechanism is still unknown. Thus it is necessary to exploit the mechanism of Eucommia ulmoides Oliv.
   Methods: A systems pharmacology approach combining drug-likeness evaluation, oral bioavailability prediction, multiple drug targets prediction as well as network pharmacology techniques has been used.
   Results: This comprehensive systematic approach helps successfully to identify 41 candidate compounds contained in Eucommia ulmoides Oliv. while 39 potential targets hit by these ingredients and helps to uncover the synergistic mechanism of action on a systematic level.
   Conclusions: Our work successfully explains the mechanism of the efficiency of Eucommia ulmoides Oliv. for the treatment of hypertension and enhancing immune. These results not only provide a new insight for the understanding of the chemical and pharmacological basis of Eucommia ulmoides Oliv., but also provide an efficient way for drug discovery from herbal medicine. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Pre One:噻吩和三唑酮类Chk1抑制剂的特征结构研究

Next One:Insight into the binding mode and the structural features of the pyrimidine derivatives as human A(2A) adenosine receptor antagonists